DDL logo
Menu
  • The Aerosol Society logo
DDL logo
  • DDL2026
    • Delegate Registration
    • Lecture Programme
    • Speakers
    • The DDL Incubator
    • Attending Exhibitors and Sponsors
    • New Researcher Network
    • Hotel and Travel
    • Media Partners
    • Frequently Asked Questions
  • Archive
    • Conference Papers Archive
    • DDL2025
      • Lecture Recordings
      • Conference Papers
      • Lecture Programme
      • EPAG Workshop
      • Speakers
      • Exhibitors and Sponsors
      • Photo Album
    • DDL2024
      • Lecture Recordings
      • Conference Papers
      • Lecture Programme
      • Speakers
      • Exhibitors and Sponsors
      • Photo Album
    • DDL2023
      • Lecture Recordings
      • The Association of Inhalation Toxicologists – Workshop
      • Conference Papers
      • Lecture Programme
      • Speakers
      • Exhibitors and Sponsors
      • Photo Album
    • DDL2022
      • Lecture Recordings
      • Academy of Pharmaceutical Sciences – Workshop
      • Conference Papers
      • Lecture Programme
      • Speakers
      • Exhibitors and Sponsors
      • Photo Album
    • DDL2021
      • Conference Papers
      • Lecture Programme
      • Speakers
      • Sponsors
    • Previous Years Conferences
  • DDL Annual Lecture
  • Awards & Grants
    • DDL Career Development Grant
    • The DDL Emerging Scientist Award
    • The Pat Burnell Young Investigator Award
    • Aerosol Society Awards
  • About
    • Gallery
    • History
    • DDL Charter
    • Committee
    • The Scientific Advisors
    • Contact
  • Associated Events
    • Annual Aerosol Science Conference
    • RDD 2027
    • USP Workshop
  • The Aerosol Society logo
Dr Rui Churro

Dr Rui Churro

Hovione

Rui Churro earned his PhD degree (Cum Laude) in the field of Refining, Petrochemical and Chemical Engineering at Faculdade de Engenharia, Universidade do Porto in 2020 with a thesis dedicated to heterogeneous catalysis. In 2020, he joined Hovione as a Drug Product Development Scientist, having been involved in drug product and drug product intermediate process development from early stage through commercial scale. In 2022, he has been leading process development and internal R&D projects in the respiratory field, focusing on spray drying, capsule filling, and formulation strategies for the Inhalation and Advanced Drug Delivery group as a Senior Scientist. Recently, since 2025, he has been responsible for leading the Drug Product development team of the Inhalation and Advanced Drug Delivery group at Hovione, which focuses on the development of formulations, processes and devices for nasal and inhalation products.

  • Terms
  • Privacy & Cookie policy
  • Contact
  • Committee

© 2026 Drug Delivery to the Lungs Website design: definingdesign.co.uk